Showing results (1-10 of 198) with videos related to

Sort By:
Pageof 20
Expert Review of Anticancer Therapy|May 9, 2017
Novel agents in mantle cell lymphomaDavid Tucker, Simon Rule
British Journal of Haematology|May 24, 2020
The 5-year follow-up of a real-world observational study of patients in the United Kingdom and Ireland receiving ibrutinib for relapsed/refractory mantle cell lymphomaDavid Tucker, Nick Morley, Peter MacLean, et al.
Hematology. American Society of Hematology. Education Program|December 4, 2016
Frontline therapy and role of high-dose consolidation in mantle cell lymphomaSimon Rule
Hospital Medicine (London, England : 1998)|June 30, 2004
Managing cancer-related skeletal events with bisphosphonatesSimon Rule
Hematological Oncology|June 13, 2019
The modern approach to mantle cell lymphomaSimon Rule
Cancer Journal (Sudbury, Mass.)|August 1, 2020
Advances in Classification and Treatment of Non-Hodgkin Lymphoma: Mantle CellSimon Rule, Sophie Johns
Blood|December 16, 2014
Mantle cell lymphoma: evolving management strategiesElias Campo, Simon Rule
Best Practice & Research. Clinical Haematology|February 18, 2018
What is the optimal initial management of the younger mantle cell lymphoma patient?Rory McCulloch, Simon Rule
Expert Review of Hematology|March 10, 2018
Does maintenance therapy have a role in mantle cell lymphoma treatment?Madeliene Parrott, Simon Rule
Clinical Medicine Insights. Oncology|January 19, 2012
Emerging Pharmacotherapy for Relapsed or Refractory Hodgkin's Lymphoma: Focus on Brentuximab VedotinMichelle Furtado, Simon Rule
Pageof 20